2019
DOI: 10.1136/ijgc-2018-000038
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma

Abstract: ObjectiveUterine carcinosarcoma (UCS) is a highly aggressive neoplasm that is composed of an intricate admixture of carcinomatous and sarcomatous elements. The relationship between UCS and the epithelial to mesenchymal transition (EMT) has been reported. In this study, we examined how expression of E-cadherin was associated with the expression of EMT-related proteins in UCS.MethodsUCS samples were histologically divided into three components: carcinomatous, transitional, and sarcomatous regions. Next, we exami… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 26 publications
0
8
0
Order By: Relevance
“…In addition, we noted that some tumor cells in the mesenchymal component displayed weak immunoreactivity for EMA and CK7, accompanied with a significant reduction or loss of expression of those epithelial markers in the adjacent epithelial component. Given the fact that uterine conventional carcinosarcoma is currently considered as a metaplastic high-grade endometrial carcinoma [57,58], our findings raise the possibility that MLCS may be also a metaplastic MLA in which the mesenchymal component retains at least partially the morphological and/or immunohistochemical features of MLA (i.e., the mesenchymal morphology of MLCS may represent a result of epithelial-mesenchymal transition or transdifferentiation of MLA). Further studies are necessary to investigate whether uterine MLCS shows similar immunohistochemical and molecular features to those of MLA and to confirm the monoclonal origin of uterine MLCS.…”
Section: Discussionmentioning
confidence: 83%
“…In addition, we noted that some tumor cells in the mesenchymal component displayed weak immunoreactivity for EMA and CK7, accompanied with a significant reduction or loss of expression of those epithelial markers in the adjacent epithelial component. Given the fact that uterine conventional carcinosarcoma is currently considered as a metaplastic high-grade endometrial carcinoma [57,58], our findings raise the possibility that MLCS may be also a metaplastic MLA in which the mesenchymal component retains at least partially the morphological and/or immunohistochemical features of MLA (i.e., the mesenchymal morphology of MLCS may represent a result of epithelial-mesenchymal transition or transdifferentiation of MLA). Further studies are necessary to investigate whether uterine MLCS shows similar immunohistochemical and molecular features to those of MLA and to confirm the monoclonal origin of uterine MLCS.…”
Section: Discussionmentioning
confidence: 83%
“…When categorized into carcinomatous, transitional and sarcomatous regions, it was observed that the sarcomatous region of tissues showed higher EMT expression markers, namely ZEB1 and SNAI2, as compared to the carcinomatous region. Moreover, the level of ZEB1 was higher in the sarcomatous region when compared to the transitional region [ 93 ]. Similar to UCS, ovarian carcinosarcoma (OCS) showed enriched expression of EMT markers when compared to the cohort of high-grade serous carcinoma in TCGA [ 87 ], suggesting that OCS indicates phenotypic and/or lineage plasticity signatures through the EMT landscape.…”
Section: Cellular and Lineage Plasticity In Cancermentioning
confidence: 99%
“…The tissue was categorized into carcinomatous, transitional and sarcomatous regions and it was observed that the sarcomatous region showed higher EMT expression markers, namely ZEB1 and SNAI2 when compared to the carcinomatous region. Also, the level of ZEB1 was higher in the sarcomatous region when compared to the transitional region [93]. Similar to UCS, ovarian carcinosarcoma (OCS) showed enriched expression of EMT markers when compared to the cohort of high-grade serous carcinoma in TCGA [87] suggesting that OCS indicates phenotypic and/or lineage plasticity signatures through the EMT landscape.…”
Section: Epithelial-mesenchymal Plasticitymentioning
confidence: 99%